Pharma and Biotech
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | 257.4% |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | n/a | (0.99) | (0.59)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | n/a | (1.34) | (0.46)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | n/a | (1.86) | (0.64)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | n/a | (1.59) | (0.47)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-25 | n/a | (1.42) | (0.33)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Primary Endpoint in SLAB Clinical Trial Met | 08-Sep-2026 | 07:00 | RNS |
| Patent Update | 03-Aug-2026 | 07:00 | RNS |
| Result of AGM | 29-Jun-2026 | 12:02 | RNS |
No recent information was found.
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 1.88p |
| Change Today | -0.050p |
| % Change | -2.60 % |
| 52 Week High | 2.93 |
| 52 Week Low | 0.93 |
| Volume | 1,642,495 |
| Shares Issued | 566.41m |
| Market Cap | £10.62m |
| Beta | 0.00 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:53 | 42 @ 1.93p |
| 15:27 | 219 @ 1.93p |
| 13:40 | 197,675 @ 1.85p |
| 13:37 | 194,396 @ 1.89p |
| 10:45 | 6,030 @ 1.91p |
You are here: research